Normandy Hadrontherapy (NHa) is a medtech company engineering a cyclotron-based particle therapy system, the C400 IONS, being more compact, more affordable, and easier to use and maintain than existing systems. The superconducting cyclotron is the heart of the world's first compact multi-ions therapy system (carbon, heliums proton and others). This innovative solution will offer advanced heavy-ion therapy with benefits for many cancer indications, especially for large, hypoxic and radio resistant tumors.
Company Details
- Employees
- 41
- Founded
- 2019
- Address
- 1, Rue Claude Bloch, Caen,normandie 14000,france
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Keywords
- Cancer Treatment and Medicam Device.
- HQ
- Caen, Normandie
Normandy Hadrontherapy Questions
Normandy Hadrontherapy's LinkedIn profile is https://fr.linkedin.com/company/normandy-hadrontherapy
Normandy Hadrontherapy has
41 employees.
View email and phone details for 41
employees at Normandy Hadrontherapy.
Normandy Hadrontherapy's industry is
Medical Equipment Manufacturing
Normandy Hadrontherapy's top competitors are
Heidelberg Ion-Beam Therapy Center (Hit),
Cyclhad,
Lifthing,
Centre François Baclesse,
Hitriplus,
Le Smartsitting,
Axon' Mechatronics,
Iba,
Proton Center Of Arkansas,
Centro Nazionale Di Adroterapia Oncologica (Cnao).
Normandy Hadrontherapy's categories are Medical Equipment Manufacturing
Normandy Hadrontherapy's founding year is 2019
